Release Details
Living with DMD, Ukraine
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results
April 22, 2014
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial ResultsSOUTH PLAINFIELD, NJ April 22, 2014 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2014 financial results on Tuesday, May 6, 2014 at 4:30 p.m. (ET) after the closing of the market.
The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 33834345. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at www.ptcbio.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for two weeks.
ABOUT PTC THERAPEUTICS, INC. PTC is biopharmaceutical company focused on the discovery and development of orally administered, proprietary small molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and which form the basis for collaborations with leading biopharmaceutical companies. For more information on the company, please visit our website www.ptcbio.com.
FOR MORE INFORMATION PLEASE CONTACT: Jane Baj +1 (908) 912-9167 jbaj@ptcbio.com
The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 33834345. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at www.ptcbio.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for two weeks.
ABOUT PTC THERAPEUTICS, INC. PTC is biopharmaceutical company focused on the discovery and development of orally administered, proprietary small molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and which form the basis for collaborations with leading biopharmaceutical companies. For more information on the company, please visit our website www.ptcbio.com.
FOR MORE INFORMATION PLEASE CONTACT: Jane Baj +1 (908) 912-9167 jbaj@ptcbio.com